Stitch Fix Posts Q4 Results, Joins Transocean, MBX Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
1. U.S. stock futures showed mixed signals with minor Dow gains. 2. MBX Biosciences fell 5.5% to $19.00 amid public offering news. 3. Upsized public offerings typically pressure stock prices short-term. 4. Market sentiment generally negative with several biotech stocks declining. 5. Similar trends observed in other companies announcing public offerings.